Determina N. 472 del 03/05/2016

Struttura: Direzione sanitaria ospedaliera

AUTORIZZAZIONE ALLO SVOLGIMENTO DELLO STUDIO CLINICO "A TWENTY-SIX WEEK, RANDOMIZED, OPEN-LABEL, 2-ARM PARALLEL GROUP REAL WORLD PRAGMATIC TRIAL TO ASSESS THE CLINICAL AND HEALTH OUTCOMES BENEFIT OF TOUJEO COMPARED TO STANDARD OF CARE INSULIN FOR INITIATING BASAL INSULIN NAVE PATIENTS WITH UNCONTROLLED TYPE 2 DIABETES MELLITUS, WITH 6-MONTH EXTENSION" PRESSO LA SOC MALATTIE METABOLICHE E DIABETOLOGIA DELL'ASL VCO